5-hydroxymethylcytosine has been researched along with Astrocytoma, Grade IV in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Cain, JE; Jayasekara, WSN; St John, JC; Sun, X; Vaghjiani, V | 1 |
Astudillo, A; Bayón, GF; Bigot, T; Carella, A; Chiara, MD; Corte-Torres, MD; Fernández, AF; Fraga, MF; García, MG; García-Toraño, E; López, V; Mangas, C; Meléndez, B; Mollejo, M; Pérez, RF; Sáenz-de-Santa-María, I; Santamarina-Ojeda, P; Sierra, M; Tejedor, JR; Urdinguio, RG | 1 |
Akiyama, T; Ino, Y; Katou, Y; Koyama-Nasu, R; Kozuka-Hata, H; Masuda, K; Morishita, Y; Mukasa, A; Nasu-Nishimura, Y; Ogawa, H; Oyama, M; Saito, N; Sakaguchi, Y; Sato, T; Shirahige, K; Suzuki, T; Takai, H; Todo, T; Toyoshima, C | 1 |
Greiner, A; Guibourt, V; Kolck, G; Kraus, TF; Kretzschmar, HA; Schierl, K | 1 |
Christensen, BC; Fadul, CE; Houseman, EA; Johnson, KC; King, JE; von Herrmann, KM | 1 |
Becker, A; Denkhaus, D; Freihoff, D; Freihoff, J; Gessi, M; Hammes, J; Isselstein, LJ; Luxen, D; Müller, T; Pietsch, T; Simon, M; Waha, A; zur Mühlen, A | 1 |
6 other study(ies) available for 5-hydroxymethylcytosine and Astrocytoma, Grade IV
Article | Year |
---|---|
The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma.
Topics: 5-Methylcytosine; Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; DNA Copy Number Variations; DNA Methylation; DNA, Mitochondrial; Genotype; Glioblastoma; Humans; Immunoprecipitation; Mice; Mitochondria; Neoplasm Transplantation; Osteosarcoma; Whole Genome Sequencing | 2018 |
Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
Topics: 5-Methylcytosine; Animals; Biopsy; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Dioxygenases; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Code; Humans; Mice; Prognosis; RNA, Messenger; Survival Analysis; Xenograft Model Antitumor Assays | 2020 |
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.
Topics: 5-Methylcytosine; Acetylation; Brain Neoplasms; Carcinogenesis; Chromatin; Cytosine; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Glioblastoma; HEK293 Cells; Histones; Humans; Methylation; Mixed Function Oxygenases; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins; Repressor Proteins; Transcription Factors; Transcription, Genetic | 2014 |
Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Epigenesis, Genetic; Female; Glioblastoma; Histones; Humans; Isocitrate Dehydrogenase; Ki-67 Antigen; Loss of Heterozygosity; Male; Middle Aged; Mutation; Prognosis; Promoter Regions, Genetic; Tumor Suppressor Proteins | 2015 |
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Brain Neoplasms; DNA Methylation; DNA, Neoplasm; Enhancer Elements, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Prefrontal Cortex; Survival Analysis; Transcription Factors | 2016 |
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cytosine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Dual-Specificity Phosphatases; Female; Gene Expression Regulation, Enzymologic; Glioblastoma; Glioma; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Mitogen-Activated Protein Kinase Phosphatases; Mixed Function Oxygenases; Mutation; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Subcellular Fractions; Tumor Suppressor Proteins | 2012 |